Effectiveness of antidepressants - Meta-analysis of dose-effect relationships in randomised clinical trials

被引:217
作者
Bollini, P
Pampallona, S
Tibaldi, G
Kupelnick, B
Munizza, C
机构
[1] Ctr Studi & Rich Psichiatria, I-10154 Turin, Italy
[2] ForMed, Evolene, Switzerland
关键词
D O I
10.1192/bjp.174.4.297
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Antidepressant drugs are usually prescribed at low doses, possibly to avoid adverse reactions. No comprehensive review has addressed the issue of dose, clinical response and tolerability in a quantitative way. Aims To determine whether high doses of antidepressants are more effective than lowdoses, and how safety is affected by dose. Method Trials comparing two or more doses of the same antidepressant were located, and all antidepressants administered were converted to the equivalent dose of imipramine. Generalised estimating equations were used to analyse percentage improvement and adverse event rate according to dose level. Results Thirty-three studies were identified. The dose level 100-200 mg imipramine equivalents showed an average improvement of 53% by 'intention-to-treat', Higher doses were not accompanied by increased efficacy, while lower doses showed reduction in efficacy. Adverse events significantly increased with dose. Conclusions With a low dose of antidepressants, clinicians trade off a slightly reduced chance of improvement for a higher chance of avoiding adverse reactions.
引用
收藏
页码:297 / 303
页数:7
相关论文
共 75 条
[31]  
FONTAINE R, 1994, J CLIN PSYCHIAT, V55, P234
[32]   COMPARISON OF FULL-DOSE VERSUS HALF-DOSE PHARMACOTHERAPY IN THE MAINTENANCE TREATMENT OF RECURRENT DEPRESSION [J].
FRANK, E ;
KUPFER, DJ ;
PEREL, JM ;
CORNES, C ;
MALLINGER, AG ;
THASE, ME ;
MCEACHRAN, AB ;
GROCHOCINSKI, VJ .
JOURNAL OF AFFECTIVE DISORDERS, 1993, 27 (03) :139-145
[33]   MOCLOBEMIDE TWICE-DAILY IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODE - A DOUBLE-BLIND, MULTICENTER COMPARISON WITH DIFFERENT 3 TIMES DAILY DOSAGE SCHEDULES [J].
GAGIANO, CA ;
MULLER, FGM ;
BERK, M ;
JOUBERT, PM ;
BROWN, RGCW ;
SCHALL, R .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (04) :S4-S9
[34]  
GRAM LF, 1990, CLIN NEUROPHARMACOL, V13, pS35
[35]  
GREENBERG RP, 1989, LIMITS BIOL TREATMEN, P1
[36]  
GRINGRAS M, 1975, J INT MED RES, V3, P47
[37]   DOUBLE-BLIND DOSE DETERMINATION STUDY OF A NEW ANTIDEPRESSANT - SERTRALINE [J].
GUY, W ;
MANOV, G ;
WILSON, WH .
DRUG DEVELOPMENT RESEARCH, 1986, 9 (04) :267-272
[38]  
Guy W., 1976, Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, MD, U.S. Department of Health, Education, and Welfare, Public health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, DHEW Publ No ADM 76-338, pp 218-222., P218
[39]  
HALARIS AE, 1983, J CLIN PSYCHIAT, V44, P101
[40]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62